Parallel Advisors, LLC Genmab A/S Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Genmab A/S stock. As of the latest transaction made, Parallel Advisors, LLC holds 620 shares of GMAB stock, worth $12,765. This represents 0.0% of its overall portfolio holdings.

Number of Shares

620

Previous 400 55.0%

Holding current value

$12,765

Previous $10,000 50.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$23.84 - $28.48 $5,244 - $6,265	220 Added 55.0%	620 $15,000
Q2 2024 Aug 08, 2024	SELL	$25.13 - $30.27 $32,493 - $39,139	-1,293 Reduced 76.37%	400 $10,000
Q1 2024 May 06, 2024	BUY	$26.43 - $32.77 $17,734 - $21,988	671 Added 65.66%	1,693 $50,000
Q4 2023 Feb 09, 2024	SELL	$27.94 - $35.44 $5,755 - $7,300	-206 Reduced 16.78%	1,022 $32,000
Q3 2023 May 20, 2024	BUY	$35.27 - $42.24 $2,468 - $2,956	70 Added 6.04%	1,228 $43,000
Q3 2023 Nov 13, 2023	BUY	$35.27 - $42.24 $2,468 - $2,956	70 Added 6.04%	1,228 $43,000
Q2 2023 May 20, 2024	BUY	$37.4 - $42.94 $15,334 - $17,605	410 Added 54.81%	1,158 $44,000
Q2 2023 Aug 04, 2023	BUY	$37.4 - $42.94 $15,334 - $17,605	410 Added 54.81%	1,158 $44,000
Q1 2023 May 20, 2024	SELL	$34.88 - $43.22 $32,961 - $40,842	-945 Reduced 55.82%	748 $28,000
Q1 2023 Apr 25, 2023	BUY	$34.88 - $43.22 $2,790 - $3,457	80 Added 11.98%	748 $28,000
Q4 2022 Feb 03, 2023	SELL	$33.8 - $47.06 $14,533 - $20,235	-430 Reduced 39.16%	668 $28,000
Q3 2022 Nov 10, 2022	BUY	$31.52 - $373.61 $14,814 - $175,596	470 Added 74.84%	1,098 $35,000
Q2 2022 Aug 01, 2022	SELL	$26.83 - $38.57 $11,000 - $15,813	-410 Reduced 39.5%	628 $20,000
Q1 2022 Apr 28, 2022	SELL	$30.95 - $39.68 $10,027 - $12,856	-324 Reduced 23.79%	1,038 $38,000
Q4 2021 Jan 20, 2022	SELL	$35.87 - $47.12 $19,728 - $25,916	-550 Reduced 28.77%	1,362 $54,000
Q3 2021 Nov 02, 2021	BUY	$41.55 - $48.72 $23,268 - $27,283	560 Added 41.42%	1,912 $84,000
Q2 2021 Aug 06, 2021	BUY	$32.88 - $44.57 $11,836 - $16,045	360 Added 36.29%	1,352 $55,000
Q1 2021 Apr 23, 2021	SELL	$30.92 - $44.4 $1,855 - $2,664	-60 Reduced 5.7%	992 $33,000
Q4 2020 Feb 02, 2021	BUY	$33.66 - $40.76 $2,019 - $2,445	60 Added 6.05%	1,052 $43,000
Q3 2020 Oct 27, 2020	BUY	$33.07 - $38.68 $8,598 - $10,056	260 Added 35.52%	992 $36,000
Q2 2020 Jul 16, 2020	BUY	$20.05 - $33.89 $10,225 - $17,283	510 Added 229.73%	732 $24,000
Q1 2020 Apr 27, 2020	SELL	$17.15 - $25.22 $171 - $252	-10 Reduced 4.31%	222 $4,000
Q4 2019 Jan 30, 2020	BUY	$18.88 - $24.14 $4,380 - $5,600	232 New	232 $5,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Genmab A/S Transaction History